Department of Family Medicine, University of Calgary, 108-30 Springborough Blvd SW, Calgary, AB T3H 0N9, Canada.
Medicina (Kaunas). 2023 Jan 10;59(1):140. doi: 10.3390/medicina59010140.
Several new quantitative fertility monitors are now available for at-home use that measure estrogen, luteinizing hormone (LH), and progesterone (PDG) in urine. This case report compares the Mira and Inito quantitative fertility monitors with the well-established qualitative ClearBlue fertility monitor. Three clinical scenarios were evaluated: a normal cycle, a prolonged luteinization cycle, and an anovulatory cycle. The identification of the luteal phase (or lack thereof in the case of anovulation) and the transition through the three processes of luteinization, progestation, and luteolysis were clearly demarcated with the help of quantitative LH and PDG. Quantitative fertility monitors have the potential to identify details of the luteal phase to help women with regular cycles and abnormal luteal phases to help target interventions for optimizing fertility.
目前有几种新的定量生育监测器可供家庭使用,可测量尿液中的雌激素、促黄体生成素(LH)和孕酮(PDG)。本病例报告比较了 Mira 和 Inito 定量生育监测器与成熟的定性 ClearBlue 生育监测器。评估了三种临床情况:正常周期、黄体期延长和无排卵周期。定量 LH 和 PDG 的帮助下,黄体期(或无排卵情况下的缺乏)的识别以及通过黄体化、孕激素和黄体溶解三个过程的过渡都被清晰地标定。定量生育监测器有可能识别黄体期的细节,帮助有规律周期和黄体期异常的女性进行干预,以优化生育能力。